Hydralyte USA secures A$392,000 through a share placement, appoints two new non-executive directors, and implements significant cost reductions following CEO resignation as it targets cash-flow break-even and strategic expansion.
- A$392k placement at $0.004 per share
- 49 million options granted, subject to shareholder approval
- CEO Oliver Baker resigns, replaced by e-commerce lead Emily Lease
- Board remuneration halved to A$120,000 annually
- Strategic M&A opportunities to be explored
Capital Raise to Fuel US Sales Momentum
Hydralyte USA (ASX:HPC) has secured a modest A$392,000 via a placement of 98 million shares priced at $0.004 each, matching the recent closing price. The funds, raised through a firm commitment from investor George Karafotios, will primarily support the company’s sales push in the US and shore up working capital. Alongside the placement, Hydralyte USA plans to issue 49 million options exercisable at $0.006, a 50% premium, pending shareholder approval.
Board Overhaul and Management Changes Signal New Direction
The capital raise coincides with a significant shake-up in Hydralyte USA’s leadership. CEO Oliver Baker has resigned but will remain involved as a consultant to smooth the transition. The company’s e-commerce lead, Emily Lease, steps up as General Manager, tasked with overseeing daily operations and commercial execution across channels.
Meanwhile, the board welcomes two new non-executive directors: George Karafotios, a restructuring specialist with a track record in ASX-listed turnarounds, and Nick Katiforis, a financial services veteran with deep capital markets experience. Their appointments replace outgoing Chair Adem Karafili and director Joseph Constable, with Nick Berry assuming the chair role. Board fees have been slashed by 50%, from about A$243,000 to A$120,000 annually, reinforcing the company’s drive to cut costs.
Cost Savings and Strategic Ambitions
Hydralyte USA expects these leadership changes and board remuneration cuts to reduce operating expenses by roughly A$500,000 annually. This follows earlier cost-cutting efforts, including headcount reductions and supply chain fixes that have helped stabilise inventory and sales channels.
The company is targeting a pathway to cash-flow break-even in its US operations, leveraging high-margin SKUs and e-commerce growth. Management anticipates improved operating cash flow from the third quarter of FY26, supported by normalising sales after previous disruptions and better inventory positioning heading into the US summer peak.
Exploring M&A to Scale Platform
Beyond organic growth, Hydralyte USA plans to explore strategic mergers and acquisitions to add scale and strengthen its balance sheet. The new directors’ expertise in restructuring and capital markets is expected to guide these efforts, potentially unlocking shareholder value through accretive deals.
Non-Executive Chair Nick Berry highlighted the company’s strengthened financial flexibility and leadership as key enablers for advancing US operations and pursuing value-accretive opportunities. The company’s focus remains on consolidating recent growth trends and positioning for sustainable profitability.
Bottom Line?
Hydralyte USA’s fresh capital and revamped leadership set the stage for a tighter cost base and strategic growth, but delivering on cash-flow break-even and successful M&A will be critical tests ahead.
Questions in the middle?
- Will shareholder approval be granted for the 49 million options, and how might that affect dilution?
- How quickly can the new General Manager and board convert cost savings into improved cash flow?
- What types of M&A opportunities is Hydralyte USA targeting to scale its US platform?